Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
JW Therapeutics
company
About
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $100M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Feb 1, 2016
- Number Of Employee
- 51 - 100
- Operating Status
- Active
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$190M
JW Therapeutics has raised a total of
$190M
in funding over 2 rounds. Their latest funding was raised on
Jun 11, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 11, 2020 | Series B | $100M | 1 | — | — | Detail |
| Mar 7, 2018 | Series A | $90M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
JW Therapeutics is funded by 2 investors.
ARCH Venture Partners
and AVICT Global Holdings
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
